Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04066595
Title Cabozantinib in Patients With Locally Advanced or Metastatic Urothelial Cell Carcinoma. (CabUC)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Johannes Gutenberg University Mainz

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma



Age Groups: adult | senior
Covered Countries DEU

No variant requirements are available.